Literature DB >> 22318007

Vasopressor use in adult patients.

Nadia Ferguson-Myrthil1.   

Abstract

Vasopressors are a heterogeneous potent class of medications designed to increase blood pressure in emergent hypotensive situations. The goal of therapy is to increase blood pressure and maintain adequate perfusion, allowing nutrient and oxygen delivery to vital organs. Norepinephrine, phenylephrine, dopamine, epinephrine, and vasopressin are five vasopressors available in the United States. All vasopressors, with the exception of vasopressin, are titratable and dosed on a continuum according to clinical effect. With their different clinical features, adverse effects, and range of potency, the clinical situation usually guides therapy. Outcome data comparing different vasopressors have not demonstrated a clear mortality benefit of any one vasopressor over another, and physician preference also guides therapy. Norepinephrine, nonetheless, remains one of the preferred choices for a variety of hypotensive states, including cardiogenic and septic shock.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318007     DOI: 10.1097/CRD.0b013e31824e2294

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  8 in total

1.  Interception of the endotoxin-induced arterial hyporeactivity to vasoconstrictors.

Authors:  Shuang Zhang; Ningren Cui; Shanshan Li; Lei Guo; Yang Wu; Daling Zhu; Chun Jiang
Journal:  Vascul Pharmacol       Date:  2014-04-30       Impact factor: 5.773

2.  Functional outcome of prolonged refractory status epilepticus.

Authors:  Alexandre Lai; Hervé D Outin; Julien Jabot; Bruno Mégarbane; Stéphane Gaudry; Rémi Coudroy; Guillaume Louis; Francis Schneider; Nicolas Barbarot; Antoine Roch; Nicolas Lerolle; David Luis; François Fourrier; Anne Renault; Laurent Argaud; Tarek Sharshar; Sébastien Gibot; Pierre-Edouard Bollaert
Journal:  Crit Care       Date:  2015-04-30       Impact factor: 9.097

3.  Bolus norepinephrine and phenylephrine for maternal hypotension during elective cesarean section with spinal anesthesia: a randomized, double-blinded study.

Authors:  Xian Wang; Mao Mao; Su-Su Zhang; Zhao-Hui Wang; Shi-Qin Xu; Xiao-Feng Shen
Journal:  Chin Med J (Engl)       Date:  2020-03-05       Impact factor: 2.628

4.  Anesthetic management of cesarean section in a patient with Takayasu's arteritis: a case report.

Authors:  Taichi Ando; Makoto Sumie; Shoichi Sasaki; Miho Yoshimura; Keiko Nobukuni; Jun Maki; Katsuyuki Matsushita; Kazuhiro Shirozu; Midoriko Higashi; Ken Yamaura
Journal:  JA Clin Rep       Date:  2022-01-05

5.  Comparison of norepinephrine and phenylephrine infusions for maintenance of haemodynamics following subarachnoid block in lower segment caeserean section.

Authors:  Kanika Goel; Neeru Luthra; Namrata Goyal; Anju Grewal; Ashima Taneja
Journal:  Indian J Anaesth       Date:  2021-08-25

Review 6.  Cardiovascular effect of epinephrine in endodontic microsurgery: a review.

Authors:  Youngjune Jang; Euiseong Kim
Journal:  Restor Dent Endod       Date:  2013-11-12

7.  Catecholamine and volume therapy for cardiac surgery in Germany--results from a postal survey.

Authors:  Christoph Sponholz; Christoph Schelenz; Konrad Reinhart; Uwe Schirmer; Sebastian N Stehr
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

8.  [The effect of epinephrine for the treatment of spinal-hypotension: comparison with norepinephrine and phenylephrine, clinical trial].

Authors:  Ebru Biricik; Feride Karacaer; İlker Ünal; Mete Sucu; Hakkı Ünlügenç
Journal:  Braz J Anesthesiol       Date:  2020-09-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.